301075.SZ
多瑞医药
SZSE · C 制造业 · CN
CNY 53.75
+0.09%Margins
Gross margin
4.9%
EBITDA margin
-57.5%
EBIT margin
-90.8%
Net margin
-73.3%
FCF margin
-137.5%
-16.3%
Return on equity
-7.6%
Return on assets
-16.2%
Return on invested capital
0.11x
Asset turnover
-CNY 66.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026